Taste, pain, or response to stress—nearly all essential functions in the human body are regulated by molecular switches ...

Researchers confirm and explore the role of estrogen-related receptors in regulating energy production in muscle cells during exercise. The findings indicate that developing a drug to boost ...

Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

An investigational oral selective orexin receptor 2 agonist significantly improved measures of wakefulness, sleepiness, and ...

GLP-1 receptor agonists are reshaping obesity care. OHE highlights access challenges, prescribing policy, and how patient and ...

The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...

Patients who stop using weight loss medications are likely to return to their baseline weight within two years, a new ...

Results from a phase 3 clinical trial suggest that taking ubrogepant at the first sign of an oncoming migraine can prevent ...